Liver Transplant Oncology

The Liver Transplant Oncology Special Interest Group's mission is to build a global alliance with all medical professionals in the fields of transplantation medicine and oncology to improve the outcomes and investigate disease mechanisms of patients with hepatobiliary malignancies under the concept of transplant oncology.

 

The four pillars (4 E’s) of transplant oncology are:

  1. Evolution of multidisciplinary cancer care by integrating organ transplantation.
  2. Extension of conventional cancer surgery by applying transplantation techniques.
  3. Elucidation of self and non-self-recognition system by linking tumor and transplant immunology.
  4. Exploration of the genomic mechanisms of carcinogenesis.

Vision: We shall be the indivisible core to consolidate global efforts to save our patients with intractable cancer and their family. The ILTS SIG in Transplant Oncology should lead advances in the field and foster international collaborative scientific efforts.

SIG Objectives:

  1. Fostering Collaboration Across Disciplines: Enhance collaboration between transplantation medicine, immunology, oncology, and other specialties with the primary goal of improving patient survival and outcomes.

  2. Organizing Educational and Collaborative Events: Coordinate conferences, workshops, and consortia with leading oncology and transplant societies to develop, share, and implement guidelines and research findings.

  3. Developing National Registries: Establish multicenter national registries for patients undergoing transplantation or liver cancer treatment, with a focus on rare indications.

  4. Advancing Clinical Trials: Design and execute multicenter, multinational clinical trials and protocols specifically for liver cancer patients.

 Helpful Resources: